Karen Krueger, MD, provides insight into the role Infectious Disease providers can play in the World Health Organization’s recently announced Global Arborvirus Initiative.
No crisis should go unexploited for its potential to improve health care delivery.
Dr Robert Popovian discusses access to immunization services among adults in low-income communities and efforts to expand pharmacists’ authority to administer vaccines to increase vaccination rates for this vulnerable population.
In this interview, Paritosh Prasad, MD, provides insight into the recent outbreak of monkeypox.
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Investigators assessed the efficacy of a novel microbiome therapeutic, SER-109, for the treatment of recurrent C difficile infection.
Researchers evaluated the safety and efficacy of the investigational, microbiota-based, live biotherapeutic RBX2660 for treatment of recurrent C difficile infection.
Researchers conducted a study to determine the rates of human papillomavirus (HPV) infection among adolescent girls and young women in New York City who received the HPV vaccine following its approval in 2007.
Investigators conducted a study to determine whether cytomegalovirus affects epigenetic age and immune dysregulation in healthy older adults who are asymptomatic.
